QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Advaxis
(OTCQX:ADXS)
0.0649
-0.1751[-72.96%]
At close: May 19
15 minutes delayed
Day High/Low- - -
52 Week High/Low0.06 - 0.76
Open / Close- / -
Float / Outstanding145.6M / 145.6M
Vol / Avg.- / 488K
Mkt Cap9.5M
P/E-
50d Avg. Price0.1
Div / Yield-
Payout Ratio-
EPS0
Total Float-

Advaxis (OTC:ADXS), Quotes and News Summary

Advaxis (OTC: ADXS)

Day High/Low- - -
52 Week High/Low0.06 - 0.76
Open / Close- / -
Float / Outstanding145.6M / 145.6M
Vol / Avg.- / 488K
Mkt Cap9.5M
P/E-
50d Avg. Price0.1
Div / Yield-
Payout Ratio-
EPS0
Total Float-
Benzinga - May 12, 2022, 5:00PM
Benzinga - Jan 11, 2022, 8:10AM
Benzinga - Dec 17, 2021, 8:02AM
Benzinga - Nov 24, 2021, 8:06AM
Benzinga - Nov 23, 2021, 6:39AM
Benzinga - Nov 19, 2021, 8:03AM
Benzinga - Nov 18, 2021, 8:17AM
Benzinga - Sep 10, 2021, 12:28PM
Benzinga - Sep 10, 2021, 8:32AM
Benzinga - Aug 25, 2021, 5:28PM
Benzinga - Aug 11, 2021, 8:12AM
Benzinga - Jul 15, 2021, 8:53AM
Benzinga - Jul 15, 2021, 8:06AM
load more
Sector: Health Care.Industry: Biotechnology
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-06-13
REV
Q1 2022Est.ActualSurprise
EPS0.000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Advaxis Questions & Answers

Q
How do I buy Advaxis (ADXS) stock?
A

You can purchase shares of Advaxis (OTCQX: ADXS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Advaxis's (ADXS) competitors?
A

There are no as such competitors for Advaxis.

Q
What is the target price for Advaxis (ADXS) stock?
A

The latest price target for Advaxis (OTCQX: ADXS) was reported by HC Wainwright & Co. on Tuesday, December 18, 2018. The analyst firm set a price target for 0.00 expecting ADXS to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Advaxis (ADXS)?
A

The stock price for Advaxis (OTCQX: ADXS) is $0.0649 last updated May 19, 2022, 7:57 PM UTC.

Q
Does Advaxis (ADXS) pay a dividend?
A

There are no upcoming dividends for Advaxis.

Q
When is Advaxis (OTCQX:ADXS) reporting earnings?
A

Advaxis’s Q2 earnings are confirmed for Monday, June 13, 2022.

Q
Is Advaxis (ADXS) going to split?
A

There is no upcoming split for Advaxis.

Q
What sector and industry does Advaxis (ADXS) operate in?
A

Advaxis is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.